Eli Lilly used its voucher for orforglipron, approved on April 1, 2026, under the brand name Foundayo, and described by the agency as the fastest approval of a new molecular entity since 2002
As weight decreases and appetite regulation improves, some patients may also experience improvements in cardiovascular health, blood sugar regulation, and metabolic function
Some patients reported losing interest in alcohol and cigarettes after starting the medications
It also improves dull and tired skin as well as poor sleep quality
Causation One of the biggest challenges in understanding the relationship between semaglutide and blood clots is distinguishing correlation from causation
When you eat, this bag stretches